PS-341 in Treating Patients With Metastatic Malignant Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of PS-341 in treating patients who have metastatic
malignant melanoma. Drugs used in chemotherapy use different ways to stop tumor cells from
dividing so they stop growing or die